1.
Reimbursement for taxoids in the Netherlands
2.
3.
4.
5.
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands
The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: A population based study in the Netherlands
Risk of new primary nonbreast cancers after breast cancer treatment: A dutch population-based study